Journal article
Assessment of cardiovascular safety of anti-osteoporosis drugs
- Abstract:
-
The incidence of osteoporosis and cardiovascular disease increases with age, and there are potentially shared mechanistic associations between the two conditions. It is therefore highly relevant to understand the cardiovascular implications of osteoporosis medications. These are presented in this narrative review. Calcium supplementation could theoretically cause atheroma formation via calcium deposition, and in one study was found to be associated with myocardial infarction, but this has not...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, 967.2KB, Terms of use)
-
- Publisher copy:
- 10.1007/s40265-020-01364-2
Authors
Bibliographic Details
- Publisher:
- Springer
- Journal:
- Drugs More from this journal
- Volume:
- 80
- Issue:
- 15
- Pages:
- 1537–1552
- Publication date:
- 2020-07-28
- Acceptance date:
- 2020-06-23
- DOI:
- EISSN:
-
1179-1950
- ISSN:
-
0012-6667
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1114582
- Local pid:
-
pubs:1114582
- Deposit date:
-
2020-06-24
Terms of use
- Copyright holder:
- Fuggle et al.
- Copyright date:
- 2020
- Rights statement:
- © The Author(s) 2020. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record